Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,834 | 176 | 589 | 712 | 1,371 |
| Receivables | N/A | 256 | N/A | N/A | N/A |
| TOTAL | $1,932 | $541 | $700 | $823 | $1,493 |
| Non-Current Assets | |||||
| PPE Net | 6 | 7 | 8 | 10 | 13 |
| Other Non-Current Assets | 21 | 21 | 21 | 0 | 16 |
| TOTAL | $27 | $28 | $29 | $10 | $29 |
| Total Assets | $1,959 | $569 | $729 | $833 | $1,522 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 130 |
| Accounts payable and accrued liabilities | 567 | 235 | 267 | 268 | 275 |
| TOTAL | $707 | $235 | $267 | $268 | $502 |
| Non-Current Liabilities | |||||
| Long Term Debt | 493 | 916 | 649 | 309 | 170 |
| Deferred Revenues | 140 | N/A | N/A | N/A | 96 |
| Other Non-Current Liabilities | 0 | 3 | 1 | 0 | 0 |
| TOTAL | $1,449 | $1,448 | $1,203 | $886 | $675 |
| Total Liabilities | $2,155 | $1,683 | $1,470 | $1,154 | $1,177 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,441 | 17,871 | 17,871 | 17,871 | 17,851 |
| Common Shares | 40,251 | 38,844 | 38,802 | 38,779 | 38,718 |
| Retained earnings | -40,542 | -40,052 | -39,637 | -39,194 | -38,467 |
| TOTAL | $-197 | $-1,114 | $-740 | $-321 | $345 |
| Total Liabilities And Equity | $1,959 | $569 | $729 | $833 | $1,522 |